$NBIO announced today that the Protocol for the Phase 2 clinical trials was submitted to the FDA for review and approval. The review is required for approval to commence the next phase in the development of Pritumumab ("PTB"
.
https://finance.yahoo.com/news/nascent-submit...00457.html